(Q79443212)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17180529%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

title

Early relapse in multiple sclerosis-associated optic neuritis following the use of interferon beta-1a in Chinese patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17180529%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1 reference

1 reference

An-Guor Wang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17180529%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Yen-Ching Lin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17180529%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Shuu-Jiun Wang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17180529%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Ching-Piao Tsai

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17180529%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

May-Yung Yen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17180529%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

publication date

1 November 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17180529%20AND%20SRC:MED&resulttype=core&format=json

Japanese Journal of Ophthalmology

23 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17180529%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

volume

50

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17180529%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17180529%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

page(s)

537-542

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17180529%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10384-006-0359-4

23 December 2019

exact match

0 references

cites work

Interferon beta in multiple sclerosis

1 reference

12 December 2020

Comparison of the clinical courses of the opticospinal and conventional forms of multiple sclerosis in Japan.

1 reference

12 December 2020

Multiple sclerosis in the Japanese population

1 reference

12 December 2020

Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group

1 reference

12 December 2020

High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial

1 reference

12 December 2020

Contemporary immunomodulatory therapy for multiple sclerosis

1 reference

12 December 2020

Western vs optic-spinal MS: two diseases, one treatment?

1 reference

12 December 2020

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group

1 reference

12 December 2020

Epidemiological study of multiple sclerosis in Hong Kong Chinese: questionnaire survey

1 reference

12 December 2020

Racial modification of clinical picture of multiple sclerosis: comparison between British and Japanese patients

1 reference

12 December 2020

Exacerbations of multiple sclerosis in patients treated with gamma interferon

1 reference

12 December 2020

A long-term prospective study of optic neuritis: evaluation of risk factors

1 reference

12 December 2020

Interferon-gamma-secreting cells in multiple sclerosis patients treated with interferon beta-1b

1 reference

12 December 2020

Multiple sclerosis amongst Chinese in Taiwan

1 reference

12 December 2020

Incidence of exacerbations in the first 90 days of treatment with recombinant human interferon beta-1b in patients with relapsing-remitting multiple sclerosis.

1 reference

12 December 2020

Optic neuritis: prognosis for multiple sclerosis from MRI, CSF, and HLA findings

1 reference

12 December 2020

Low conversion rate to multiple sclerosis in idiopathic optic neuritis patients in Taiwan.

1 reference

12 December 2020

Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis. European Study Group on interferon beta-1b in secondary progressive MS

1 reference

12 December 2020

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

12 December 2020

Interferon beta-1b is effective in Japanese RRMS patients: a randomized, multicenter study

1 reference

12 December 2020

Optic neuritis treatment trial. One-year follow-up results

1 reference

12 December 2020

The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up.

1 reference

12 December 2020

Multiple sclerosis in Taiwan

1 reference

12 December 2020

Brain magnetic resonance imaging in acute optic neuritis. Experience of the Optic Neuritis Study Group.

1 reference

12 December 2020

Optic neuritis: A population-based study in Olrnsted County, Minnesota

1 reference

12 December 2020